TY - JOUR
T1 - Monitoring physical activity using wearable technology in people with Achilles tendinopathy undergoing physiotherapy treatment
T2 - A feasibility prospective cohort study
AU - Oskouei, Sanam Tavakkoli
AU - Malliaras, Peter
AU - Hill, Keith D.
AU - Clark, Ross
AU - Perraton, Luke
N1 - Funding Information:
The authors would like to thank all physiotherapists and participants in this study. The study protocol was approved by the Monash University Human Research Ethics Committee (MUHREC), Australia (ID: 26358). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Publisher Copyright:
© 2023 Chartered Society of Physiotherapy
PY - 2023/9
Y1 - 2023/9
N2 - Objectives: Physical activity modification is an important part of the management of Achilles tendinopathy. However, to our knowledge, there is a lack of evidence on objective physical activity assessment in Achilles tendinopathy. The purpose of this study is to (1) assess feasibility of using an inertial measurement unit (IMU) to monitor physical activity and IMU-derived biomechanical measures over 12-week treatment course by a physiotherapist; (2) conduct a preliminary analysis of changes in physical activity over 12-weeks. Design: A feasibility prospective cohort study Setting: A community setting. Participants: People with Achilles tendinopathy who had recently commenced (≤2 sessions), or were about to commence, treatment with a physiotherapist Main outcome measures: Participants wore a shank-mounted IMU on the affected side for one week at baseline, 6-, and 12-week follow-ups. The outcomes were pain/symptom severity, IMU-derived physical activity and biomechanical measures (stride rate, peak shank angular velocity, and peak shank acceleration). Results: Thirty participants were recruited. There was a high retention rate (97%), response rate (97%), and IMU wear compliance at each timepoint (>93%). For pain/symptom severity, a significant time effect was observed between baseline and 12-week follow-up. Physical activity and IMU-derived biomechanical measures did not change over 12 weeks. Physical activity decreased at the 6-week follow-up but only returned to the baseline level at 12-week follow-up. Conclusions: A larger-scale cohort study assessing clinical outcomes and physical activity appears feasible. Preliminary data indicate that physical activity may not change significantly over 12-weeks in people undergoing physiotherapy management for Achilles tendinopathy. Contribution of the paper: • A larger-scale cohort study assessing physical activity using wearable technology over 12 weeks of treatment by a physiotherapist appears feasible. • Preliminary findings indicate physical activity may not change significantly over 12-weeks of treatment by a physiotherapist for people with Achilles tendinopathy. • Changes in pain and symptom severity after 12 weeks of treatment by a physiotherapist are not correlated with changes in physical activity level.
AB - Objectives: Physical activity modification is an important part of the management of Achilles tendinopathy. However, to our knowledge, there is a lack of evidence on objective physical activity assessment in Achilles tendinopathy. The purpose of this study is to (1) assess feasibility of using an inertial measurement unit (IMU) to monitor physical activity and IMU-derived biomechanical measures over 12-week treatment course by a physiotherapist; (2) conduct a preliminary analysis of changes in physical activity over 12-weeks. Design: A feasibility prospective cohort study Setting: A community setting. Participants: People with Achilles tendinopathy who had recently commenced (≤2 sessions), or were about to commence, treatment with a physiotherapist Main outcome measures: Participants wore a shank-mounted IMU on the affected side for one week at baseline, 6-, and 12-week follow-ups. The outcomes were pain/symptom severity, IMU-derived physical activity and biomechanical measures (stride rate, peak shank angular velocity, and peak shank acceleration). Results: Thirty participants were recruited. There was a high retention rate (97%), response rate (97%), and IMU wear compliance at each timepoint (>93%). For pain/symptom severity, a significant time effect was observed between baseline and 12-week follow-up. Physical activity and IMU-derived biomechanical measures did not change over 12 weeks. Physical activity decreased at the 6-week follow-up but only returned to the baseline level at 12-week follow-up. Conclusions: A larger-scale cohort study assessing clinical outcomes and physical activity appears feasible. Preliminary data indicate that physical activity may not change significantly over 12-weeks in people undergoing physiotherapy management for Achilles tendinopathy. Contribution of the paper: • A larger-scale cohort study assessing physical activity using wearable technology over 12 weeks of treatment by a physiotherapist appears feasible. • Preliminary findings indicate physical activity may not change significantly over 12-weeks of treatment by a physiotherapist for people with Achilles tendinopathy. • Changes in pain and symptom severity after 12 weeks of treatment by a physiotherapist are not correlated with changes in physical activity level.
KW - Biomechanics
KW - Tendinopathy
KW - Walking
KW - Wearable sensor
UR - http://www.scopus.com/inward/record.url?scp=85162923752&partnerID=8YFLogxK
U2 - 10.1016/j.physio.2023.04.001
DO - 10.1016/j.physio.2023.04.001
M3 - Article
C2 - 37364446
AN - SCOPUS:85162923752
SN - 0031-9406
VL - 120
SP - 38
EP - 46
JO - Physiotherapy
JF - Physiotherapy
ER -